drugset / Trial / NCT00532337
Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-5334 in postmenopausal women with osteopenia or osteoporosis.
Timeline
- Start
- 2007-10
- Primary completion
- 2010-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | 70 mg | — |
| Comparator | ONO-5334 | Unknown | 50 mg | — |
| Comparator | ONO-5334 | Unknown | 100 mg | — |
| Comparator | ONO-5334 | Unknown | 300 mg | — |